Real-world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day 28, for patients infected with highly resistant metallo-beta lactamase ...
In a study to identify risk factors and outcomes in extended-spectrum beta-lactamose-producing Enterobacteriaceae infections in pediatric patients, researchers found 77 percent of the infections were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results